Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.89%
1,083.04
-9.76
-0.89%
—1,092.801,093.681,094.851,081.97——
SIXC
Communications
SIXC
Communications
SIXC
-0.39%
602.38
-2.36
-0.39%
—604.74604.74605.10601.34——
SIXE
Energy
SIXE
Energy
SIXE
+2.31%
1,242.83
+28.03
+2.31%
—1,214.801,220.811,243.821,220.81——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.62%
1,713.82
-10.75
-0.62%
—1,724.571,727.021,732.301,707.43——
SIXM
Financials
SIXM
Financials
SIXM
+0.09%
639.99
+0.56
+0.09%
—639.43641.58644.53637.50——
SIXR
Staples
SIXR
Staples
SIXR
-0.20%
837.46
-1.69
-0.20%
—839.15836.90840.48832.89——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.65%
214.22
-1.40
-0.65%
—215.62215.62216.21213.48——
SIXT
Technology
SIXT
Technology
SIXT
+0.78%
3,204.38
+24.86
+0.78%
—3,179.523,191.503,205.093,177.75——
SIXU
Utilities
SIXU
Utilities
SIXU
-1.23%
925.38
-11.53
-1.23%
—936.91935.42937.17923.20——
SIXV
Health care
SIXV
Health care
SIXV
-0.69%
1,442.71
-10.06
-0.69%
—1,452.771,445.931,447.431,434.91——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.16%
2,361.34
-3.84
-0.16%
—2,365.182,353.642,368.102,347.80——
STAR:NSE
Strides Pharma Science Ltd
₹1,037.40
-1.52%
(-16.05) 1D
Apr 30, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for STAR...
Open
₹1,050.00
High
₹1,051.45
Low
₹1,026.15
Mkt. cap
95.62B
Avg. vol.
267.68K
Volume
202.49K
Dividend
0.39%
Quarterly dividend
₹1.00
Ex dividend date
Jul 22, 2025
P/E ratio
18.70
52-wk high
₹1,110.00
52-wk low
₹615.00
EPS
₹55.49
Shares outstanding
89.55M
No. of employees
3K
News stories
From sources across the web
Profile
Strides Pharma Science Limited is an Indian pharmaceutical company, headquartered at Bangalore. The company manufactures pharmaceutical products, over-the-counter drugs and nutraceuticals. Products include softgel capsules, hard-gel capsules, tablets and dry and wet injectables. The company has 15 manufacturing sites in six countries and marketing presence in 50 countries. The company partners with generic companies to supply retail and hospital generics in injectable products and softgels. The company's stock trades on the Bombay Stock Exchange and on the National Stock Exchange of India. Strides Arcolab changed name to Strides Shasun Ltd after an amalgamation of Shasun Pharmaceuticals with Strides Arcolab. In September 2014, the Board of Directors of both the companies had approved a scheme of amalgamation between the two companies. Arun Kumar is the founder and chairman, and has been on the board as managing director since its inception. Wikipedia
About Strides Pharma Science Ltd
CEO-
Employees3.3K
Founded1990
HeadquartersBengaluru, Karnataka, India
SectorPharmaceutical industry
Websitestrides.com
Last report
Jan 30, 2026
Fiscal Period
Q3 2026
Normalized EPS / Estimate
-/ -INR
Revenue / Estimate
11.95B/ (12.54B est.)INR
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
11.90B
11.20B
12.21B
11.95B
Cost of goods sold
6.47B
4.44B
5.15B
4.63B
Cost of revenue
6.47B
4.44B
5.15B
4.63B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.93B
2.26B
2.27B
2.30B
Operating expense
3.75B
5.06B
5.24B
5.46B
Total operating expenses
10.23B
9.51B
10.39B
10.09B
Operating income
1.68B
1.69B
1.82B
1.85B
Other non operating income
-836.32M
-388.77M
271.40M
1.07B
EBT including unusual items
1.06B
1.22B
1.53B
2.45B
EBT excluding unusual items
1.30B
1.30B
1.62B
2.49B
Income tax expense
207.59M
164.50M
215.93M
373.53M
Effective tax rate
19.51%
13.48%
14.10%
15.22%
Other operating expenses
334.18M
2.32B
2.47B
2.66B
Net income
821.94M
996.08M
1.28B
2.02B
Net profit margin
6.90%
8.90%
10.45%
16.92%
Earnings per share
-
-
-
-
Interest and investment income
479.95M
-
-
-
Interest expense
-89.02M
-
-461.27M
-433.79M
Net interest expenses
390.93M
-
-461.27M
-433.79M
Depreciation and amortization charges
488.60M
488.86M
496.43M
506.23M
EBITDA
2.08B
2.09B
2.31B
2.25B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer